
Reset all filters
01 7Canakinumab/PF
02 1Canakinumab/PF
Reset all filters
01 12880935
02 15032608
03 111412685
04 115141639
05 117711823
06 125811119
07 133488914
08 139279713.03
Reset all filters
01 12016
02 12017
03 12018
04 12019
05 12020
06 12021
07 12022
08 12023
Company : Novartis
Canakinumab/PF
Drug Cost (USD) : 39,279,713
Year : 2023
Prescribers : 229
Prescriptions : 1379
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Novartis
Canakinumab/PF
Drug Cost (USD) : 33,488,914
Year : 2022
Prescribers : 187
Prescriptions : 1214
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Novartis
Canakinumab/PF
Drug Cost (USD) : 25,811,119
Year : 2021
Prescribers : 155
Prescriptions : 984
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Novartis
Canakinumab/PF
Drug Cost (USD) : 17,711,823
Year : 2020
Prescribers : 124
Prescriptions : 701
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Novartis
Canakinumab/PF
Drug Cost (USD) : 15,141,639
Year : 2019
Prescribers : 103
Prescriptions : 610
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Novartis
Canakinumab/PF
Drug Cost (USD) : 11,412,685
Year : 2018
Prescribers : 81
Prescriptions : 502
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Novartis
Canakinumab/PF
Drug Cost (USD) : 2,880,935
Year : 2017
Prescribers : 48
Prescriptions : 136
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Novartis
Canakinumab/PF
Drug Cost (USD) : 5,032,608
Year : 2016
Prescribers : 48
Prescriptions : 243
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF